PMID- 26662303 OWN - NLM STAT- MEDLINE DCOM- 20170206 LR - 20200624 IS - 1423-0380 (Electronic) IS - 1010-4283 (Linking) VI - 37 IP - 5 DP - 2016 May TI - miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1. PG - 6761-8 LID - 10.1007/s13277-015-4575-8 [doi] AB - Recently, microRNAs (miRNAs), a kind of small and non-coding RNA, can target the downstream molecules. Increasing evidence demonstrates that miRNAs meditate the onset and progression of a variety of tumors. In the present study, we carried out gene transfection, western blot, and reverse transcription PCR (RT-PCR) to explore the role of miR-22 in glioblastoma tissues and cell lines. Here, we verified that the expression of miR-22 was downregulated in glioblastoma tissues and cells rather than matched non-tumor tissues and normal human astrocyte (NHA) cells (p < 0.001). By contrast, SIRT1 messenger RNA (mRNA) and protein were upregulated in glioblastoma tissues and cells (p < 0.001). In vitro miR-22 mimics interfered with cell proliferation, migration, and invasion of U87 and U251 cells. Mechanically, the 3'-untranslated regions (3'-UTRs) of SIRT1 were a direct target of miR-22, leading to the decreased expression of SIRT1 protein in U87 and U251 cells. Meanwhile, miR-22 mimics also inhibited the expression of epidermal growth factor receptor (EGFR) and matrix metallopeptidase 9 (MMP9). In conclusion, miR-22 inhibited cell proliferation, migration, and invasion via targeting the 3'-UTR of SIRT1 in the progression of glioblastoma and miR-22-SIRT1 pathway can be recommended as a potential target for treatment of glioblastoma. FAU - Chen, Hanchun AU - Chen H AD - Department of Neurosurgery, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou, Jiangsu, 215021, People's Republic of China. FAU - Lu, Qiong AU - Lu Q AD - Department of Laboratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai, 200433, People's Republic of China. FAU - Fei, Xifeng AU - Fei X AD - Department of Neurosurgery, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou, Jiangsu, 215021, People's Republic of China. FAU - Shen, Likui AU - Shen L AD - Department of Neurosurgery, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou, Jiangsu, 215021, People's Republic of China. FAU - Jiang, Dongyi AU - Jiang D AD - Department of Neurosurgery, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou, Jiangsu, 215021, People's Republic of China. FAU - Dai, Dongwei AU - Dai D AD - Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai, 200433, People's Republic of China. daidwshanghai@163.com. LA - eng PT - Journal Article DEP - 20151210 PL - Netherlands TA - Tumour Biol JT - Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine JID - 8409922 RN - 0 (3' Untranslated Regions) RN - 0 (MIRN22 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (RNA, Messenger) RN - EC 3.5.1.- (Sirtuin 1) SB - IM MH - 3' Untranslated Regions MH - Cell Line, Tumor MH - Cell Movement MH - Cell Proliferation MH - Gene Expression Profiling MH - *Gene Expression Regulation, Neoplastic MH - Glioblastoma/*genetics/mortality/pathology MH - Humans MH - MicroRNAs/chemistry/*genetics MH - *RNA Interference MH - RNA, Messenger/chemistry/genetics MH - Sirtuin 1/chemistry/*genetics MH - Transcriptome OTO - NOTNLM OT - Glioblastoma OT - SIRT1 OT - miR-22 EDAT- 2015/12/15 06:00 MHDA- 2017/02/07 06:00 CRDT- 2015/12/15 06:00 PHST- 2015/11/14 00:00 [received] PHST- 2015/12/01 00:00 [accepted] PHST- 2015/12/15 06:00 [entrez] PHST- 2015/12/15 06:00 [pubmed] PHST- 2017/02/07 06:00 [medline] AID - 10.1007/s13277-015-4575-8 [pii] AID - 10.1007/s13277-015-4575-8 [doi] PST - ppublish SO - Tumour Biol. 2016 May;37(5):6761-8. doi: 10.1007/s13277-015-4575-8. Epub 2015 Dec 10.